Brittany Jones
PR & Marketing Manager
(571) 459-8626
Brittany.Jones@fairfaxcityecondev.org
Fairfax City Economic Development (FCED) announces the arrival of Genetix IQ, a leading biotechnology company, to its dynamic business landscape. This significant addition follows the recent modernization of Fairfax City’s zoning rules, marking a pivotal step in expanding the City’s technological and innovative ecosystem.
Genetix IQ specializes in advanced genetic technology, offering new rapid and accurate molecular diagnostics for disease identification and healthcare treatments in women’s health, gastrointestinal analysis, and several other common healthcare needs. FCED led the modernization of the zoning legislation, paving the way for high-tech, research-based businesses to flourish and invest in the community. Fairfax City aims to foster collaboration between biotechnology firms and other local businesses to enhance public health and support various scientific projects.
“Biotechnology companies are on the leading edge of revolutionary advancements essential to solving critical challenges across the globe. We welcome Genetix IQ to Fairfax City and look forward to their success within a very diverse community of businesses that have chosen to locate here,” said Fairfax City Mayor Catherine S. Read. “As a small city at the epicenter of an economically robust region, we offer a level of support and attention to our businesses that is unique.”
“In a post-COVID world, we are taking a deeper dive into what types of tenants require in-person participation, and innovations in fields like biotech fits that bill,” Nicole Toulouse, Senior Vice President of Business Investment of Fairfax City Economic Development added. “We are thrilled that Genetix IQ continues to add to the innovation economy in Fairfax City.”
The arrival of Genetix IQ signifies a milestone in Fairfax City’s ongoing efforts to support modern entrepreneurial firms and adapt to evolving industry trends.
To learn more about Genetix IQ, please visit genetixiq.com.